엘라스토메릭 인퓨전 펌프 시장(2026-2030년)

The global elastomeric infusion pumps market is forecasted to grow by USD 982.1 mn during 2025-2030, accelerating at a CAGR of 7.2% during the forecast period. The report on the global elastomeric infusion pumps market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by surging prevalence of chronic pathologies requiring long-term continuous therapies, accelerated shift toward home healthcare and decentralized clinical settings, urgent institutional mandates for minimizing electronic medication errors.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global elastomeric infusion pumps market is segmented as below:

By Application

• Pain management
• Antibiotic or antiviral
• Chemotherapy
• Others

By End-User

• Hospitals
• Ambulatory service centers
• Clinics
• Others

By Product

• Continuous rate
• Variable rate

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the technological evolution in medical grade elastomeric membranes as one of the prime reasons driving the global elastomeric infusion pumps market growth during the next few years. Also, macroeconomic expansion across emerging geographic markets and pediatric and neonatal specialty infusion customization will lead to sizable demand in the market.

The report on the global elastomeric infusion pumps market covers the following areas:

• Global elastomeric infusion pumps market sizing
• Global elastomeric infusion pumps market forecast
• Global elastomeric infusion pumps market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global elastomeric infusion pumps market vendors that include Ace Medical Co. Ltd., Ambu AS, Amsino International Inc., Avanos Medical Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Daiken Medical Co. Ltd., Epic Medical, Henan Tuoren Medical Device, Max Plus India, Moog Inc., Nipro Corp., Owens and Minor Inc., pfm medical gmbh, Promecon GmbH, SCW Medicath Ltd., Spirit Medical Ltd., Vygon SA, WooYoung Medical Co. Ltd.. Also, the global elastomeric infusion pumps market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Elastomeric Infusion Pumps Market 2020 - 2024
  • Historic Market Size - Data Table on Global Elastomeric Infusion Pumps Market 2020 - 2024 ($ million)
• 5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Elastomeric Infusion Pumps Market
• 6.2 Impact of geopolitical conflicts on Global Elastomeric Infusion Pumps Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 Pain management - Market size and forecast 2025-2030
• 8.4 Antibiotic or antiviral - Market size and forecast 2025-2030
• 8.5 Chemotherapy - Market size and forecast 2025-2030
• 8.6 Others - Market size and forecast 2025-2030
• 8.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2025-2030
• 9.4 Ambulatory service centers - Market size and forecast 2025-2030
• 9.5 Clinics - Market size and forecast 2025-2030
• 9.6 Others - Market size and forecast 2025-2030
• 9.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Product

• 10.1 Market segments
• 10.2 Comparison by Product
• 10.3 Continuous rate - Market size and forecast 2025-2030
• 10.4 Variable rate - Market size and forecast 2025-2030
• 10.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 Turkey - Market size and forecast 2025-2030
  • 12.6.4 South Africa - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 UAE - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Surging prevalence of chronic pathologies requiring long-term continuous therapies
  • Accelerated shift toward home healthcare and decentralized clinical settings
  • Urgent institutional mandates for minimizing electronic medication errors
• 13.2 Market challenges
  • Flow accuracy control failures
  • Data connectivity integration obstacles
  • Institutional reimbursement policy variations
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Technological evolution in medical grade elastomeric membranes
  • Macroeconomic expansion across emerging geographic markets
  • Pediatric and neonatal specialty infusion customization

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Ambu AS
  • Ambu AS - Overview
  • Ambu AS - Business segments
  • Ambu AS - Key offerings
  • Ambu AS - Segment focus
  • SWOT
• 15.5 Amsino International Inc.
  • Amsino International Inc. - Overview
  • Amsino International Inc. - Product / Service
  • Amsino International Inc. - Key offerings
  • SWOT
• 15.6 Avanos Medical Inc.
  • Avanos Medical Inc. - Overview
  • Avanos Medical Inc. - Business segments
  • Avanos Medical Inc. - Key offerings
  • Avanos Medical Inc. - Segment focus
  • SWOT
• 15.7 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key offerings
  • SWOT
• 15.8 Baxter International Inc.
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Segment focus
  • SWOT
• 15.9 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.10 Epic Medical
  • Epic Medical - Overview
  • Epic Medical - Product / Service
  • Epic Medical - Key offerings
  • SWOT
• 15.11 Henan Tuoren Medical Device
  • Henan Tuoren Medical Device - Overview
  • Henan Tuoren Medical Device - Product / Service
  • Henan Tuoren Medical Device - Key offerings
  • SWOT
• 15.12 Moog Inc.
  • Moog Inc. - Overview
  • Moog Inc. - Business segments
  • Moog Inc. - Key offerings
  • Moog Inc. - Segment focus
  • SWOT
• 15.13 Nipro Corp.
  • Nipro Corp. - Overview
  • Nipro Corp. - Business segments
  • Nipro Corp. - Key offerings
  • Nipro Corp. - Segment focus
  • SWOT
• 15.14 Owens and Minor Inc.
  • Owens and Minor Inc. - Overview
  • Owens and Minor Inc. - Business segments
  • Owens and Minor Inc. - Key offerings
  • Owens and Minor Inc. - Segment focus
  • SWOT
• 15.15 Promecon GmbH
  • Promecon GmbH - Overview
  • Promecon GmbH - Product / Service
  • Promecon GmbH - Key offerings
  • SWOT
• 15.16 Spirit Medical Ltd.
  • Spirit Medical Ltd. - Overview
  • Spirit Medical Ltd. - Product / Service
  • Spirit Medical Ltd. - Key offerings
  • SWOT
• 15.17 Vygon SA
  • Vygon SA - Overview
  • Vygon SA - Product / Service
  • Vygon SA - Key offerings
  • SWOT
• 15.18 WooYoung Medical Co. Ltd.
  • WooYoung Medical Co. Ltd. - Overview
  • WooYoung Medical Co. Ltd. - Product / Service
  • WooYoung Medical Co. Ltd. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations